IVANO Bioscience commercializes biological reagents and analytical kits designed to enhance laboratory performance in developing new vaccines, antiviral drugs, and gene therapies.
We offer safe, functionally validated genetically-modified pseudoviruses at both small and large scales to support preclinical and clinical development needs, ensuring successful laboratory experiments.
We are also developing the next generation of neutralizing detection assays with a patent-pending kit that delivers results 10 times faster than competitors, enabling high-throughput screening in standard laboratory settings.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Quebec, Quebec G1v 0a6, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ivanobioscience.com/
- Keywords
- biotechnology, pseudovirus, biomanufacturing, viral vector, neutralization assay, infectious disease.
- HQ
- Quebec, quebec
Ivano Bioscience Questions
Ivano Bioscience's website is https://www.ivanobioscience.com/
Ivano Bioscience's LinkedIn profile is https://ca.linkedin.com/company/ivanobioscience
Ivano Bioscience has
5 employees.
View email and phone details for 5
employees at Ivano Bioscience.
Ivano Bioscience's industry is
Biotechnology Research
Ivano Bioscience's top competitors are
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Linearis,
Arsenal Biosciences, Inc.,
Thryv Therapeutics Inc.,
Transbiotech,
Saguaro Biosciences,
Aramis Biotechnologies,
Orsobio,
Biotwin,
Innodal.
Ivano Bioscience's categories are Biotechnology Research
Ivano Bioscience's founding year is 2018
